Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Clinical Trial Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Status: Enrolling
Updated:  11/30/2011
Stevenson & Associates Physical Therapy
mi
from
Fort Myers, FL
Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Clinical Trial Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Status: Enrolling
Updated: 11/30/2011
Stevenson & Associates Physical Therapy
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Clinical Trial Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Status: Enrolling
Updated:  11/30/2011
Brooks Balance Center
mi
from
Jacksonville, FL
Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Clinical Trial Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
Status: Enrolling
Updated: 11/30/2011
Brooks Balance Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Children's Hospital of Lousiana
mi
from
New Orleans, LA
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Children's Hospital of Lousiana
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Kennedy Krieger Institute
mi
from
Baltimore, MD
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Gillette Children's Speciality Healthcare
mi
from
St. Paul, MN
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Gillette Children's Speciality Healthcare
mi
from
St. Paul, MN
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Washington Univeristy - St. Louis Children's hospital
mi
from
St. Louis, MO
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Washington Univeristy - St. Louis Children's hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
SUNY Upstate Medical University
mi
from
Syracuse, NY
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Texas Children's Hospital
mi
from
Houston, TX
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Kluge Children's Rehabilitation Center - University of Virginia
mi
from
Charlottesville, VA
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Kluge Children's Rehabilitation Center - University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated:  12/2/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy
Status: Enrolling
Updated: 12/2/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Genetics of Rolandic Epilepsy
Genetics of Rolandic Epilepsy
Status: Enrolling
Updated:  12/5/2011
Mailman School of Public Health, Columbia University Medical Center, 722 West 168th St, 6th Floor
mi
from
New York, NY
Genetics of Rolandic Epilepsy
Genetics of Rolandic Epilepsy
Status: Enrolling
Updated: 12/5/2011
Mailman School of Public Health, Columbia University Medical Center, 722 West 168th St, 6th Floor
mi
from
New York, NY
Click here to add this to my saved trials
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study
Enteral Nutrition and Glycemic Variability NICU Study
Status: Enrolling
Updated:  12/7/2011
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study
Enteral Nutrition and Glycemic Variability NICU Study
Status: Enrolling
Updated: 12/7/2011
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
University of Alabama at Birmingham
mi
from
Birmingham, AL
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
UCLA
mi
from
Los Angeles, CA
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
University of Colorado Hospital
mi
from
Aurora, CO
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
Emory College of Medicine
mi
from
Atlanta, GA
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
Emory College of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
Rush University
mi
from
Chicago, IL
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
University of Kansas
mi
from
Kansas City, KA
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
University of Kansas
mi
from
Kansas City, KA
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
University of Louisville
mi
from
Louisville, KY
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
University of Maryland
mi
from
Baltimore, MD
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated:  12/8/2011
Case Western University
mi
from
Cleveland, OH
Risk Factors for Progressive Supranuclear Palsy (PSP)
Genetic and Environmental Risk Factors for PSP
Status: Enrolling
Updated: 12/8/2011
Case Western University
mi
from
Cleveland, OH
Click here to add this to my saved trials
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Thoracic Manipulation in Patients With Cervical Radiculopathy
Immediate and Short Term Effects of Thoracic Manipulation in Patients With Cervical Radiculopathy
Status: Enrolling
Updated:  12/19/2011
Spine and Sport
mi
from
Savannah, GA
Thoracic Manipulation in Patients With Cervical Radiculopathy
Immediate and Short Term Effects of Thoracic Manipulation in Patients With Cervical Radiculopathy
Status: Enrolling
Updated: 12/19/2011
Spine and Sport
mi
from
Savannah, GA
Click here to add this to my saved trials
The Natural History of Procalcitonin in Hemorrhagic Stroke
The Natural History of Procalcitonin in Hemorrhagic Stroke
Status: Enrolling
Updated:  12/21/2011
Charleston Area Medical Center
mi
from
Charleston, WV
The Natural History of Procalcitonin in Hemorrhagic Stroke
The Natural History of Procalcitonin in Hemorrhagic Stroke
Status: Enrolling
Updated: 12/21/2011
Charleston Area Medical Center
mi
from
Charleston, WV
Click here to add this to my saved trials
Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway
Phase II Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through the Vitamin D Pathway
Status: Enrolling
Updated:  12/22/2011
West Virginia University Hospitals Mary Babb Randolph Cancer Center
mi
from
Morgantown, WV
Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway
Phase II Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through the Vitamin D Pathway
Status: Enrolling
Updated: 12/22/2011
West Virginia University Hospitals Mary Babb Randolph Cancer Center
mi
from
Morgantown, WV
Click here to add this to my saved trials
Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
Re-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
Status: Enrolling
Updated:  12/28/2011
Mercy Catholic Medical Center
mi
from
Darby, PA
Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
Re-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
Status: Enrolling
Updated: 12/28/2011
Mercy Catholic Medical Center
mi
from
Darby, PA
Click here to add this to my saved trials
Endovascular Magnesium Sampling in Acute Stroke
Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke
Status: Enrolling
Updated:  12/30/2011
University California Los Angeles: Ronald Reagan and Santa Monica Hospitals
mi
from
Los Angeles, CA
Endovascular Magnesium Sampling in Acute Stroke
Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke
Status: Enrolling
Updated: 12/30/2011
University California Los Angeles: Ronald Reagan and Santa Monica Hospitals
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Endovascular Magnesium Sampling in Acute Stroke
Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke
Status: Enrolling
Updated:  12/30/2011
University of Southern California University and LA County Hospitals
mi
from
Los Angeles, CA
Endovascular Magnesium Sampling in Acute Stroke
Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke
Status: Enrolling
Updated: 12/30/2011
University of Southern California University and LA County Hospitals
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated:  1/2/2012
The Parkinson's & Movement Disorder Institute
mi
from
Fountain Valley, CA
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated: 1/2/2012
The Parkinson's & Movement Disorder Institute
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated:  1/2/2012
Department of Neurology, David Geffen School of Medicine at UCLA
mi
from
Los Angeles, CA
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated: 1/2/2012
Department of Neurology, David Geffen School of Medicine at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated:  1/2/2012
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated: 1/2/2012
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated:  1/2/2012
University of South Florida 5
mi
from
Tampa, FL
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated: 1/2/2012
University of South Florida 5
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated:  1/2/2012
Division of Movement Disorders, University of Louisville
mi
from
Louisville, KY
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated: 1/2/2012
Division of Movement Disorders, University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated:  1/2/2012
University of Medicine and Dentistry, Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated: 1/2/2012
University of Medicine and Dentistry, Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated:  1/2/2012
Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson Beelitz
mi
from
Beelitz-Heilstätten,
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112, a GSK-3 Inhibitor, Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Status: Enrolling
Updated: 1/2/2012
Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson Beelitz
mi
from
Beelitz-Heilstätten,
Click here to add this to my saved trials
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
Genome-Wide Case-Only Study of Antihypertensive Drug-Gene Interactions
Status: Enrolling
Updated:  1/4/2012
Cardiovascular Health Research Unit
mi
from
Seattle, WA
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
Genome-Wide Case-Only Study of Antihypertensive Drug-Gene Interactions
Status: Enrolling
Updated: 1/4/2012
Cardiovascular Health Research Unit
mi
from
Seattle, WA
Click here to add this to my saved trials
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
The Effect of Statins on Skeletal Muscle Function
Status: Enrolling
Updated:  1/5/2012
The Hartford Hospital
mi
from
Hartford, CT
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
The Effect of Statins on Skeletal Muscle Function
Status: Enrolling
Updated: 1/5/2012
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
The Effect of Statins on Skeletal Muscle Function
Status: Enrolling
Updated:  1/5/2012
University of Connecticut
mi
from
Storrs, CT
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
The Effect of Statins on Skeletal Muscle Function
Status: Enrolling
Updated: 1/5/2012
University of Connecticut
mi
from
Storrs, CT
Click here to add this to my saved trials
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
The Effect of Statins on Skeletal Muscle Function
Status: Enrolling
Updated:  1/5/2012
University of Massachusetts
mi
from
Amherst, MA
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
The Effect of Statins on Skeletal Muscle Function
Status: Enrolling
Updated: 1/5/2012
University of Massachusetts
mi
from
Amherst, MA
Click here to add this to my saved trials
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Status: Enrolling
Updated:  1/13/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Status: Enrolling
Updated: 1/13/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Abdominal Compression in Orthostatic Hypotension
The Efficacy of Adjustable Lower Abdominal Compression in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  1/17/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Abdominal Compression in Orthostatic Hypotension
The Efficacy of Adjustable Lower Abdominal Compression in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 1/17/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
Comparing the Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
Status: Enrolling
Updated:  1/18/2012
Columbia University Medical Center, Milstein Hospital
mi
from
New York, NY
Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
Comparing the Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
Status: Enrolling
Updated: 1/18/2012
Columbia University Medical Center, Milstein Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy
Status: Enrolling
Updated:  1/24/2012
Shriners Hospitals for Children, Northern California
mi
from
Sacramento, CA
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy
Status: Enrolling
Updated: 1/24/2012
Shriners Hospitals for Children, Northern California
mi
from
Sacramento, CA
Click here to add this to my saved trials
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy
Status: Enrolling
Updated:  1/24/2012
Alfred I duPont Childrens Hospital
mi
from
Wilmington, DE
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy
Status: Enrolling
Updated: 1/24/2012
Alfred I duPont Childrens Hospital
mi
from
Wilmington, DE
Click here to add this to my saved trials
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy
Status: Enrolling
Updated:  1/24/2012
Childrens National Medical Center
mi
from
Washington,
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy
Status: Enrolling
Updated: 1/24/2012
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials